Viking Therapeutics logo

Viking Therapeutics Share Price (NASDAQ: VKTX)

$41.78

1.75

(4.37%)

Live

Last updated on

Check the interactive Viking Therapeutics Stock chart to analyse performance

Viking Therapeutics stock performance

as on August 19, 2025 at 12:37 AM IST

  • Today's Low:$40.66
    Today's High:$42.19

    Day's Volatility :3.63%

  • 52 Weeks Low:$18.92
    52 Weeks High:$81.73

    52 Weeks Volatility :76.85%

Viking Therapeutics Stock Returns

PeriodViking Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
45.56%
2.3%
0.0%
6 Months
36.81%
-5.8%
0.0%
1 Year
-39.92%
-10.9%
0.0%
3 Years
1024.44%
2.8%
-11.6%

Viking Therapeutics, Inc. Key Stats

Check Viking Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$40.03
Open
$40.0
Today's High
$42.19
Today's Low
$40.66
Market Capitalization
$4.5B
Today's Volume
$3.3M
52 Week High
$81.7295
52 Week Low
$18.92
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.54
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-19.99%

Stock Returns calculator for Viking Therapeutics Stock including INR - Dollar returns

The Viking Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Viking Therapeutics investment value today

Current value as on today

₹66,778

Returns

₹33,222

(-33.22%)

Returns from Viking Therapeutics Stock

₹37,296 (-37.3%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Viking Therapeutics Stock

55.59%

Period: Jul 19, 2025 to Aug 18, 2025. Change in 30 Days versus previous period

Investment in Viking Therapeutics Shares from India has grown by 55.59% over the past 30 days, indicating increased transactional activity.

131%

Period: Jul 19, 2025 to Aug 18, 2025. Change in 30 Days versus previous period

Search interest for Viking Therapeutics Stock from India on INDmoney has increased by 131% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Viking Therapeutics, Inc.

  • Name

    Holdings %

  • FMR Inc

    10.00%

  • Vanguard Group Inc

    9.04%

  • BlackRock Inc

    5.32%

  • State Street Corp

    3.61%

  • JPMorgan Chase & Co

    2.78%

  • Morgan Stanley - Brokerage Accounts

    2.78%

Analyst Recommendation on Viking Therapeutics Stock

Rating
Trend

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Viking Therapeutics(by analysts ranked 0 to 5 stars)

Viking Therapeutics Share Price Target

What analysts predicted

Upside of 113.69%

Target:

$89.28

Current:

$41.78

Viking Therapeutics share price target is $89.28, a slight Upside of 113.69% compared to current price of $41.78 as per analysts' prediction.

Viking Therapeutics Stock Insights

  • Price Movement

    In the last 3 years, VKTX stock has moved up by 996.7%
  • VKTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 96.8%

Viking Therapeutics Technicals Summary

Sell

Neutral

Buy

Viking Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Viking Therapeutics, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Viking Therapeutics, Inc. logo
25.33%
36.81%
-39.92%
1024.44%
417.18%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
85.77%
36.56%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

Viking Therapeutics Dividend announcements

  • Viking Therapeutics Earnings

    Viking Therapeutics’s price-to-earnings ratio stands at None

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Organization
Viking Therapeutics
Employees
48
CEO
Dr. Brian Lian Ph.D.
Industry
Health Technology

Key Management of Viking Therapeutics, Inc.

NameTitle
Dr. Brian Lian Ph.D.
President, CEO & Director
Mr. Gregory S. Zante CPA, CPA
Chief Financial Officer
Ms. Marianne Mancini
Chief Operating Officer
Mr. Michael Morneau
Vice President of Finance & Administration
Dr. Geoffrey E. Barker Ph.D.
Chief Development Officer

Important FAQs about investing in VKTX Stock from India :

What is Viking Therapeutics share price today?

Viking Therapeutics share price today is $41.78 as on . Viking Therapeutics share today touched a day high of $42.19 and a low of $40.66.

What is the 52 week high and 52 week low for Viking Therapeutics share?

Viking Therapeutics share touched a 52 week high of $81.73 and a 52 week low of $18.92. Viking Therapeutics stock price today, is trending at $41.78, lower by 48.88% versus the 52 week high.

How to invest in Viking Therapeutics Stock (VKTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Viking Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Viking Therapeutics Shares that will get you 0.0359 shares as per Viking Therapeutics share price of $41.78 per share as on August 19, 2025 at 12:37 AM IST.

What is the minimum amount required to buy Viking Therapeutics Stock (VKTX) from India?

Indian investors can start investing in Viking Therapeutics (VKTX) shares with as little as ₹87.3775 or $1 (as of August 19, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Viking Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 19, 2025). Based on Viking Therapeutics share’s latest price of $41.78 as on August 19, 2025 at 12:37 AM IST, you will get 0.2393 shares of Viking Therapeutics. Learn more about fractional shares .

What are the returns that Viking Therapeutics has given to Indian investors in the last 5 years?

Viking Therapeutics stock has given 417.18% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?

Discover More